Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers

Gene

Volumn 525, Issue 1, 2013, Pages 18-25

  Wu, Chen ^a   Xie, Yuanyuan ^a   Gao, Feng ^b   Wang, Yanan ^a   Guo, Yawei ^a   Tian, Huanna ^a   Li, Yanshuang ^a   Fan, Wufang ^a  

^a HEBEI UNIVERSITY   (China)

^b Jiangsu Province Hospital of Traditional Chinese Medicine   (China)

Author keywords

Bmi1; Cancer stem cells; Gastric adenocarcinoma; Immunohistochemistry; Lgr5

Indexed keywords

ALDEHYDE DEHYDROGENASE; BMI1 PROTEIN; CD133 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; G PROTEIN COUPLED RECEPTOR; HERMES ANTIGEN; LEUCINE RICH REPEAT CONTAINING G PROTEIN COUPLED RECEPTOR 5; UNCLASSIFIED DRUG;

ARTICLE; CANCER STEM CELL; CONTROLLED STUDY; CYTODIAGNOSIS; DISEASE MARKER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH GLAND; STOMACH MUCOSA;

ADENOCARCINOMA; ANTIGENS, CD; CELL DIFFERENTIATION; EPITHELIUM; GASTRIC MUCOSA; HUMANS; ISOENZYMES; NEOPLASTIC STEM CELLS; POLYCOMB REPRESSIVE COMPLEX 1; RECEPTORS, G-PROTEIN-COUPLED; RETINAL DEHYDROGENASE; RETROSPECTIVE STUDIES; STEM CELLS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878878740     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.04.067     Document Type: Article

References (37)

1. Alkema M.J., Wiegant J., Raap A.K., Berns A., van L.M. Characterization and chromosomal localization of the human proto-oncogene BMI-1. Hum. Mol. Genet. 1993, 2(10):1597-1603.
2. Anderson E.C., Hessman C., Levin T.G., Monroe M.M., Wong M.H. The role of colorectal cancer stem cells in metastatic disease and therapeutic response. Cancer (Basel) 2011, 3(1):319-339.
3. Barker N., Wetering M.V.D., Clevers H. The intestinal stem cell. Genes Dev. 2008, 22(14):1856-1864.
4. Barker N., van Es J.H., Jaks V., Kasper M., Snippert H., Toftgard R., Clevers H. Very long-term self-renewal of small intestine, colon, and hair follicles from cycling Lgr5+ve stem cells. Cold Spring Harb. Symp. Quant. Biol 2008, 73:351-356.
5. Barker N., Ridgway R.A., van Es J.H., van de Wetering M., Begthel H., van den Born M., Danenberg E., Clarke A.R., Sansom O.J., Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457(7229):608-611.
6. Barker N., Huch M., Kujala P., van de Wetering M., Snippert H.J., van Es J.H., Sato T., Stange D.E., Begthel H., van den Born M., Danenberg E., van den Brink S., Korving J., Abo A., Peters P.J., Wright N., Poulsom R., Clevers H. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010, 6(1):25-36.
7. Carl-McGrath S., Lendeckel U., Ebert M., Wolter A.B., Roessner A., Röcken C. The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer. Int. J. Oncol. 2004, 25(5):1223-1232.
8. Clarke M.F., Fuller M. Stem cells and cancer: two faces of eve. Cell 2006, 124(6):1111-1115.
9. Clevers H. The cancer stem cell: premises, promises and challenges. Nat. Med. 2011, 17(3):313-319.
10. Crew K.D., Neugut A.I. Epidemiology of gastric cancer. World J. Gastroenterol. 2006, 12(3):354-362.
11. Fenoglio-Preiser C., Carneiro F., Correa P., Guilford P., Lambert R. Gastric carcinoma. Pathology and Genetics of Tumours of the Digestive System 2000, WHO classification.of tumours, Lyon-52. S.R. Hamilton, L.A. Aaltonen (Eds.).
12. Herszenyi L., Tulassay Z. Epidemiology of gastrointestinal and liver tumors. Eur. Rev. Med. Pharmacol. Sci. 2010, 14(4):249-258.
13. Ishigami S., Ueno S., Arigami T., Uchikado Y., Setoyama T., Arima H., Kita Y., Kurahara H., Okumura H., Matsumoto M., Kijima Y., Natsugoe S. Prognostic impact of CD133 expression in gastric carcinoma. Anticancer. Res. 2010, 30(6):2453-2457.
14. Itzkovitz S., Lyubimova A., Blat I., Mindy Maynard M., van Es J., Lees J., Jacks T., Clevers H., vanOudenaarden Alexander Single molecule transcript counting of stem cell markers in the mouse intestine. Nat. Cell. Biol 2011, 14(1):106-114.
15. Jiang F., Qiu Q., Khanna A., Todd N.W., Deepak J., Xing L., Wang H., Liu Z., Su Y., Stass S.A., Katz R.L. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol. Cancer Res. 2009, 7(3):330-338.
16. Katsuno Y., Ehata S., Yashiro M., Yanagihara K., Hirakawa K., Miyazono K. Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β. J. Pathol. 2012, 228(3):391-404.
17. Kleist B., Xu L., Li G., Kersten C. Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer. Int. J. Clin. Exp. Pathol. 2011, 4(4):327-335.
18. Liu S., Dontu G., Mantle I.D., Patel S., Ahn N.S., et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006, 66(12):6063-6071.
19. Liu H.G., Chen C., Yang H., Pan Y.F., Zhang X.H. Cancer stem cell subsets and their relationships. J. Transl. Med. 2011, 9:50-58.
20. Molofsky A.V., Pardal R., Iwashita T., Park I.K., Clarke M.F., Morrison S.J. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003, 425(6961):962-967.
21. Nakata S., Campos B., Becker N., Engel F., Acker T. LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells. Brain Pathol. 2013, 23(1):60-72.
22. Pang R., Law W.L., Chu A.C., Poon J.T., Lam C.S., Chow A.K., Ng L., Cheung L.W., Lan X.R., Lan H.Y., Tan V.P., Yau T.C., Poon R.T., Wong B.C. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010, 6(6):603-615.
23. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J., Clarke M.F. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003, 423(6937):302-305.
24. Proctor E., Waghray M., Lee C.J., Heidt D.G., Yalamanchili M., et al. Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma. PLoS One 2013, 8(2):e55820. 10.1371/journal.pone.0055820.
25. Qiao X.T., Ziel J.W., McKimpson W., Madison B.B., Todisco A., Merchant J.L., Samuelson L.C., Gumucio D.L. Prospective identification of a multilineage progenitor in murine stomach epithelium. Gastroenterology 2007, 133(6):1989-1998.
26. Reinisch C., Kandutsch S., Uthman A., Pammer J. BMI-1: a protein expressed in stem cells, specialized cells and tumors of the gastrointestinal tract. Histol. Histopathol. 2006, 21(1):1143-1149.
27. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De M.R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445(7123):111-115.
28. Roth S., Franken P., Sacchetti A., Kremer A., Anderson K., Sansom O. Paneth cells in intestinal homeostasis and tissue injury. PLoS One 2012, 7(6):e38965.
29. Sangiorgi E., Capecchi M.R. Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 2008, 40(7):915-920.
30. Takaishi S., Okumura T., Tu S., Wang S.S., Shibata W., Vigneshwaran R., Gordon S.A., Shimada Y., Wang T.C. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009, 27(5):1006-1020.
31. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8(10):755-768.
32. von Rahden B.H., Kircher S., Lazariotou M., Reiber C., Stuermer L., Otto C., Germer C.T., Grimm M. Lgr5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's esophagus?. J. Exp. Clin. Cancer Res. 2011, 30(1):23-33.
33. Wakamatsu Y., Sakamoto N., Oo H.Z., Naito Y., Uraoka N., Anami K., Sentani K., Oue N., Yasui W. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Pathol. Int. 2012, 62(2):112-119.
34. Walker F., Zhang H.H., Odorizzi A., Burgess A.W. LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines. PLoS One 2011, 6(7):e22733.
35. Yan K.S., Chia L.A., Li X., Ootani A., Su J., Lee J.Y., Su N., Luo Y., Heilshorn S.C., Amieva M.R., Sangiorgi E., Capecchi M.R., Kuo C.J. The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(2):466-471.
36. Yang L. Incidence and mortality of gastric cancer in China. World J. Gastroenterol. 2006, 12(1):17-20.
37. Yen T.H., Wright N.A. The gastrointestinal tract stem cell niche. Stem Cell Rev. 2006, 2(3):203-212.